ArticleJCO precision oncology2022

Durable Response to Nivolumab in a Patient With Hepatic Sarcomatoid Carcinoma: Evolutive Characterization of Genomic and Immunohistochemical PD-L1 Expression Findings.

Marcello M Queiroz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.